National Institutes of Health

Covid-19: China pushes traditional remedies amid outbreak - BBC News | 6/29/2020

… 12 components including honeysuckle, mint and liquorice. TCM’s supporters argue that there is no downside to using them but experts say rigorous scientific tests are needed before such formulas are deemed safe. The US National Institutes of Health said that while it may help with symptom relief, its overall effectiveness against the coronavirus is inconclusive. “For TCM there is no good evidence and therefore its use is not just unjustified …

How to Use Banana Peels | 6/29/2020

… a boil and simmer the peel for 10 minutes. Then, use tongs to remove the peel and pour the tea into a cup. [1] X Trustworthy Source PubMed Central Journal archive from the U.S. National Institutes of Health Go to source You can leave some of the fruit on the peel for a slightly sweet tea. Adjust the burner so the water bubbles gently as the tea brews. 2 Lay …

Follow National Institutes of Health:    

Summer may decide fate of leading shots in vaccine race | 6/29/2020

… month later with another 30,000 expected to test a British one. Those likely will be divided among Americans and volunteers in other countries such as Brazil or South Africa, Dr. Anthony Fauci of the National Institutes of Health said, reported international media on Sunday. While he’s optimistic, “we’ve been burned before,” Fauci cautioned. “This isn’t a race of who gets there first. This is, get as many approved, safe and …

54 NIH researchers with contacts with the CCP fired | 6/29/2020

54 NIH researchers with contacts with the CCP fired U.S. National Institutes Of the National Post , 15 June, 2020 The National Institutes of Health , the foremost research institute under the auspices of the U.S. Department of Health and Human Services, has investigated 189 researchers for undisclosed ties to foreign countries, 93 percent of which were linked to China. The fresh round of terminations resulted from an ongoing investigation at the …

US lockdown itself is far greater killer than Covid, each month causing 700,000 years of US lives lost. US lockdown destroys immune systems of healthy families, making them more prone to pick up any disease including a respiratory virus | 6/29/2020

… The policies have created the greatest global economic disruption in history , with trillions of dollars of lost economic output . These financial losses have been falsely portrayed as purely economic . To the contrary , using numerous National Institutes of Health Public Access publications, Centers for Disease Control and Prevention (CDC) and Bureau of Labor Statistics data, and various actuarial tables, we calculate that these policies will cause devastating non-economic consequences that …

Summer may be key turning point in fight against coronavirus: report | 6/29/2020

… month later with another 30,000 expected to test a British one. Those likely will be divided among Americans and volunteers in other countries such as Brazil or South Africa, Dr. Anthony Fauci of the National Institutes of Health told The Associated Press. While he’s optimistic, “we’ve been burned before,” Fauci cautioned. Multiple successes, in multiple parts of the world, are vital. “This isn’t a race of who gets there first …

US lockdown is far greater killer than Covid, each month causing 700,000 years of US lives lost. US lockdown destroys immune systems of healthy people, making them more prone to pick up any disease including a respiratory virus | 6/29/2020

… The policies have created the greatest global economic disruption in history , with trillions of dollars of lost economic output . These financial losses have been falsely portrayed as purely economic . To the contrary , using numerous National Institutes of Health Public Access publications, Centers for Disease Control and Prevention (CDC) and Bureau of Labor Statistics data, and various actuarial tables, we calculate that these policies will cause devastating non-economic consequences that …

Summer may decide fate of lead shots in COVID-19 vaccine race as trials begin in six continents | 6/29/2020

… month later with another 30,000 expected to test a British one. Those likely will be divided among Americans and volunteers in other countries such as Brazil or South Africa, Dr. Anthony Fauci of the National Institutes of Health told The Associated Press. While he’s optimistic, “we’ve been burned before,” Fauci cautioned. Multiple successes, in multiple parts of the world, are vital. “This isn’t a race of who gets there first …

The New Surprise of the Biological Weapon Coronavirus | 6/29/2020

… on and see what else you are going to learn. Scientists took a closer look at the effects of SARS-CoV-2 – the coronavirus that causes Covid-19 – through a powerful microscope at the National Institutes of Health laboratory in the US and the University of Freiburg in Germany. The virus makes the infected cells sprout multi-pronged spaghetti-like ‘tentacles’ reaching out for several still-healthy cells nearby. The …

Essential Science: Can blood plasma therapy reduce aging? | 6/29/2020

… to unlock the human body’s regenerative capacities. This is a limitation with the human body unlike certain other animals. New research The new research comes from University of California (Berkley), supported by the U.S. National Institutes of Health , and it looks at what happens when half of blood plasma is substituted for a mixture of saline and albumin. Study results indicate that this mixture is capable of reversing the signs …

Summer may be a key turning point in the fight against coronavirus: report | 6/29/2020

… URGES THE ‘GOAL’ OF STUDENTS ‘PHYSICALLY PRESENT IN SCHOOL’ THIS FALL They are likely to be split between Americans and volunteers in other countries like Brazil or South Africa, Dr. Anthony Fauci of the National Institutes of Health told The Associated Press. Although optimistic, “we have burned before,” Fauci warned. Multiple successes, in multiple parts of the world, are vital. “This is not a race of who comes first. That …

AIDS activists feel sense of déjà-vu as they watch the coronavirus policy battle unfold | MSN | 6/29/2020

… successfully lobbied for the Americans with Disabilities Act, making it illegal to discriminate against those with HIV or AIDS. And in 1991, his coalition’s efforts effectively doubled the budget for AIDS research at the National Institutes of Health . Now, he fears, the fight against COVID-19 will be an equally rigorous battle. But with a virus that is so much more easily transmitted, the damage will be worse. “AIDS was …

CytoDyn and NIH of Mexico Complete Memorandum of Understanding to Conduct Small Covid-19 Phase 3 Trial for Severe and Critically Ill Patients | Globe Newswire | 6/29/2020

… CYDY) , (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the Company and the Coordinating Commission of the National Institutes of Health and High Specialty Hospitals of Mexico (NIH) have entered into a Memorandum of Understanding (MOU) to conduct a COVID-19 clinical trial with leronlimab for severe and critically ill patients, with the …

CytoDyn and NIH of Mexico to conduct COVID-19 Phase 3 trial | 6/29/2020

CytoDyn ( OTCQB:CYDY ) has entered into a Memorandum of Understanding (MoU) with the Coordinating Commission of the National Institutes of Health and High Specialty Hospitals of Mexico (NIH) to conduct a COVID-19 clinical trial with leronlimab for severe and critically ill patients, with the potential to collaborate on additional COVID-19 trials. Under MoU, CytoDyn will supply leronlimab at its expense, and both parties will proceed expeditiously to complete …

CytoSorbents to Host Key Opinion Leader Call on the Use of CytoSorb Blood Purification to Remove Antithrombotic Medications in Patients at Risk of Bleeding | PR Newswire | 6/29/2020

… pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of approximately $33 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM), the U.S. Army, U.S. Special Operations Command (USSOCOM), the U.S. Air Force, Air Force Material Command (USAF/AFMC) and …

More than a dozen coronavirus vaccines are being tested; here’s what happens next | 6/29/2020

… month later with another 30,000 expected to test a British one. Those likely will be divided among Americans and volunteers in other countries such as Brazil or South Africa, Dr. Anthony Fauci of the National Institutes of Health told The Associated Press. While he’s optimistic, “we’ve been burned before,” Fauci cautioned. Multiple successes, in multiple parts of the world, are vital. “This isn’t a race of who gets there first …

Former NIH Director Has Harsh Words For Trump Administration’s Pandemic Response : Shots - Health News : NPR | 6/29/2020

Policy-ish Former NIH Director Calls Trump Administration’s Pandemic Response ‘Amateur Hour’ Facebook Twitter Flipboard Email June 29, 2020 8:21 AM ET Joe Palca Twitter Facebook Enlarge this image Bethesda, UNITED STATES: Director of the National Institutes of Health (NIH) Dr. Elias Zerhouni (R) speaks with US President George W. Bush during a round table discussion on cancer prevention at the NIH in Bethesda, Maryland, 17 January 2007. JIM WATSON …

June 29, 2020 HPI Daily Wire sponsored by Wine + Spirits Distributors of Indiana | 6/29/2020

… month later with another 30,000 expected to test a British one. Those likely will be divided among Americans and volunteers in other countries such as Brazil or South Africa, Dr. Anthony Fauci of the National Institutes of Health told The Associated Press. While he’s optimistic, “we’ve been burned before,” Fauci cautioned. “This isn’t a race of who gets there first. This is, get as many approved, safe and effective vaccines …

Landmark Study Reveals First Genetic Evidence of Sodium Pump’s Essential Function | PR Newswire | 6/29/2020

… diseases like pulmonary hypertension, obesity and diabetic retinopathy, we are better suited to treat them.” This research was supported by funds provided by (1) the BrickStreet Foundation, (2) the Huntington Foundation and (3) the National Institutes of Health (NIH) (R15 HL 145666). The work was reviewed and approved by the Marshall University Institutional Animal Care and Use Committee. Video Soundbites & B-Roll Link: https://livemarshall.sharepoint.com/:v:/s/DigitalMediaCollaboration/EX7uO6bYUgFDqdyEP_35hWsBghKps0 …

Multi-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay | Globe Newswire | 6/29/2020

… Assay™ are being utilized in a prospective observational cohort surveillance study of up to 2,000 adult participants hospitalized with COVID-19. Ten leading U.S. medical institutions are engaging in the study, sponsored by the National Institutes of Health (NIH) and entitled Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC). The study could help inform recommendations for COVID-19 care and potentially identify new strategies and optimal timing for experimental treatments …

Addiction Programs Adapt To Meet Challenges of Pandemic And A Rising Need | 6/29/2020

Earlier this year, a National Institutes of Health (NIH) examination of death certificates in the U.S. showed a sharp rise in alcohol-related deaths between 1999 and 2017. Connecticut mirrored those numbers, and addiction organizations stepped up their efforts to reach those in need. Then came the pandemic. Treatment centers, support groups and the state were suddenly ordered to shut down. “We like to say the opposite of addiction is …

Former NIH Director Has Harsh Words For Trump Administration’s Pandemic Response : Shots | 6/29/2020

JIM WATSON/AFP via Getty Images hide caption toggle caption JIM WATSON/AFP via Getty Images Bethesda, UNITED STATES: Director of the National Institutes of Health (NIH) Dr. Elias Zerhouni (R) speaks with US President George W. Bush during a round table discussion on cancer prevention at the NIH in Bethesda, Maryland, 17 January 2007. JIM WATSON/AFP via Getty Images Dr. Elias Zerhouni knows the dangers of infectious disease …

CytoDyn and NIH of Mexico Complete Memorandum of Understanding to Conduct Small Covid-19 Phase … | 6/29/2020

… CYDY) , (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the Company and the Coordinating Commission of the National Institutes of Health and High Specialty Hospitals of Mexico (NIH) have entered into a Memorandum of Understanding (MOU) to conduct a COVID-19 clinical trial with leronlimab for severe and critically ill patients, with the …

HHS: U.S. has secured 500K courses of remdesivir, a COVID-19 treatment | 6/29/2020

Supreme Court strikes down Louisiana abortion law restricting providers Remdesivir made headlines in May, when the National Institutes of Health said the antiviral drug sped up the recovery time of patients by 31%. The Health and Human Services Department said on Monday it will ship the final allocation of 120,000 treatment courses that Gilead donated amid the pandemic, which has killed over 125,000 people in the U.S. The administration said …

NA Proactive news snapshot: CytoDyn, CanaFarma Hemp Products Corp, XPhyto Therapeutics, NetCents Tec | 6/29/2020

… severe and critically ill coronavirus (COVID-19) patients, with the potential to collaborate on additional coronavirus trials. In a statement, the company said it has entered into a Memorandum of Understanding (MOU) with the National Institutes of Health and High Specialty Hospitals of Mexico (NIH), which coordinates the main medical care and public research institutions. Under the MOU, CytoDyn said it will supply leronlimab at its own expense to the …

NIH

Three decades before coronavirus, Anthony Fauci took heat from AIDS protesters | 5/20/2020

Act Up, Fight Back, Fight AIDS!” The angry chanting grew louder as hundreds of protesters wove through the usually placid campus of the National Institutes of Health in Bethesda on May 21, 1990. With signs that read, “Red Tape Kills Us,” and “NIH — Negligence, Incompetence and Horror,” the AIDS activists marched toward a row of police officers in riot gear guarding Building One. Suddenly the pack parted and a small …

Food and Drug Administration

Three decades before coronavirus, Anthony Fauci took heat from AIDS protesters | 5/20/2020

… Back, Fight AIDS!” The angry chanting grew louder as hundreds of protesters wove through the usually placid campus of the National Institutes of Health in Bethesda on May 21, 1990. With signs that read, “Red … and homophobia flourished, ACT UP staged theatrical protests at the Food and Drug Administration, on Wall Street and at New York’s City Hall. The most famous was a 1989 die-in at New York’s St …

Clinical Data

Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus | Business & Finance | manchestertimes.com | 5/18/2020

clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Immunogenicity data are currently available for the 25 µg and 100 µg dose level (ages 18-55) after two doses (day 43) and at the 250 µg level (ages 18-55) after one dose …

Department of Health and Human Services

Fired scientist Rick Bright says the US coronavirus response has been ‘chaotic’ and lacks a clear strategy | 5/18/2020

… been ‘chaotic’ and lacks a clear strategy [email protected] (Rosie Perper) Rick Bright, a scientist who was fired from the Department of Health and Human Services last month, appeared on “60 Minutes” to discuss his … and Development Authority since 2016 but was reassigned to the National Institutes of Health in April. He has said that he was fired due to resistance to push the experimental drug hydroxychloroquine as a possible …

CDC

Coronavirus Update: States Are Trying To Ensure Safe Reopening : NPR | 5/7/2020

… and it relies heavily on testing to determine when the virus is in retreat. Dr. Francis Collins, head of the National Institutes of Health, told the Senate today that his agency’s goal is to ramp … much less detail in the official White House guidelines. The CDC drafted a long list of more specific suggestions for certain businesses and religious institutions, recommending disposable or digital menus at restaurants, for example, or …

Precision Medicine

National Institutes of Health (NIH) helps fund ColCorona COVID-19 clinical study | Globe Newswire | 5/6/2020

… its clinical study on COVID-19 has received funding from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health (NIH), one of the world’s foremost medical research centers. ColCorona is … in more than 30 countries. It has specific expertise in precision medicine, low-cost high-quality clinical trials, and drug repurposing. www.mhicc.org About NYU Langone Health NYU Langone Health is a world-class, patient-centered …

Ohio State University

Straight-talking Dr. Anthony Fauci is the voice Americans want to hear right now. So, who is he? | 5/3/2020

… Pitt . Fauci’s longtime official title is director of the National Institute of Allergy and Infectious Diseases , a part of the National Institutes of Health. But since becoming the face of this country’s COVID-19 pandemic … back then, smart and humble.” Gabbe, emeritus CEO of The Ohio State University Wexner Medical Center in Columbus, lauds his friend’s sense of humor. “I’m sure he finds it entertaining that there are bobblehead dolls …

The Ohio State University

Straight-talking Dr. Anthony Fauci is the voice Americans want to hear right now. So, who is he? | MSN | 5/3/2020

… Pitt . Fauci’s longtime official title is director of the National Institute of Allergy and Infectious Diseases , a part of the National Institutes of Health. But since becoming the face of this country’s COVID-19 pandemic … met back then, smart and humble.” Gabbe, emeritus CEO of The Ohio State University Wexner Medical Center in Columbus, lauds his friend’s sense of humor. “I’m sure he finds it entertaining that there are bobblehead …

Johns Hopkins Bloomberg School of Public Health

Straight-talking Dr. Anthony Fauci is the voice Americans want to hear right now. So, who is he? | MSN | 5/3/2020

… Pitt . Fauci’s longtime official title is director of the National Institute of Allergy and Infectious Diseases , a part of the National Institutes of Health. But since becoming the face of this country’s COVID-19 pandemic … prepared, he missed it,” says Marty Makary, professor at the Johns Hopkins Bloomberg School of Public Health. “My concern is not with Anthony Fauci as much as it is in a media and policy world …

Biotech

Inside the extraordinary race to invent a coronavirus vaccine - San Antonio Express-News | 5/2/2020

… and unknowns, but eager to do his part to help end the worst pandemic in a century . Scientists at the National Institutes of Health in Bethesda, Md., will study blood from Haydon and others for … a weekend in early January, scientists at Inovio Pharmaceuticals, a biotech company outside of Philadelphia, began designing a vaccine for a mysterious pneumonia that didn’t even have a name. They, like other teams around the …

Credentialing

Opinion: Time well spent: How academic researchers can stay productive in the time of Covid-19 | 5/1/2020

… investment in academic research every year, which has led to breakthroughs in energy, water, agriculture, education, medications, and more. The National Institutes of Health received almost $42 billion in funding in fiscal year 2020. advertisement … catch up with data quality assurance checks and training and credentialing. Research ‘time well spent’ Most scientists have read the work of other scientists they have wanted to reach out to for a conversation or …

CRISPR

Covid-19’s impact on US medical research—shifting money, easing rules | BMJ | 5/1/2020

… made these decisions case by case, with guidance from their administrations, institutional review boards, and clinical trial guidance from the National Institutes of Health (NIH). With physical distancing in place, most labs have taken a … Jennifer Doudna, who helped to discover the gene editing technique CRISPR-Cas9, helped Berkeley’s Innovative Genomics Institute to create a pop-up testing lab within three weeks. It now works with the university’s healthcare center …

Medical Imaging

Remdesivir: early findings on experimental coronavirus drug offer ‘quite good news’ | World news | The Guardian | 4/30/2020

… off. The new trial was sponsored by the US’s National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Dr Anthony Fauci, a top US public health official, on Wednesday … work on equitable access to remdesivir.” Derek Hill, professor of medical imaging at University College London, pointed out that this was a randomised controlled trial, in which half the patients were given placebo, so the …

National Cancer Institute

Coronavirus (COVID-19) Update: Daily Roundup | 4/30/2020

… National Institutes of Health’s (NIH) National Cancer Institute (NCI), or by another government agency designated by FDA, and are confirmed by FDA to meet the criteria set forth in the Scope of Authorization. Under this serology “umbrella” EUA, authorized devices are intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection, by detecting antibodies (IgG, or IgG …

Cancer Therapy

Coronavirus (COVID-19) Update: Daily Roundup | PR Newswire | 4/30/2020

… unproven claims to prevent or treat COVID-19.” The FDA granted accelerated approval to a new dosing regimen for a cancer therapy, to allow patients with certain cancers to continue treatment with fewer in-person … been evaluated in an independent validation study performed at the National Institutes of Health’s (NIH) National Cancer Institute (NCI), or by another government agency designated by FDA, and are confirmed by FDA to meet the …

Socials Determinants of Health

Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Digital Technology to Improve Successful Community Reintegration of Recently Released Justice-Involved Individuals With Substance Use Disorders | PR Newswire | 4/28/2020

BOSTON , April 28, Q2i , a provider of digital health technology today announced they have been awarded a grant from the National Institute on Drug Abuse, part of the National Institutes of Health (NIH). With over 12 million arrested each year, the United States incarcerates more people both in absolute numbers and per capita than any other country in the world. Social determinants of health (SDOH) such as living conditions and …

American Heart Association

New study links severe sleep apnea to higher blood glucose levels in African Americans | National Institutes of Health (NIH) | 4/28/2020

… according to a new study funded in part by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. The findings suggest that better sleep habits may lead to better … appear online on April 28 in the Journal of the American Heart Association . “The study underscores the importance of developing interventions to promote regular sleep schedules, particularly in those with diabetes,” said Yuichiro Yano, M.D …

Diabetes Management

New study links severe sleep apnea to higher blood glucose levels in African Americans | National Institutes of Health (NIH) | 4/28/2020

… National Institutes of Health. The findings suggest that better sleep habits may lead to better blood glucose control and prove beneficial for type 2 diabetes prevention and diabetes management in African Americans, who are at higher risk for type 2 diabetes than other groups. They also point to the importance of screening for sleep apnea to help fight the potential for uncontrolled blood sugar in this high-risk group, the …

Clinical Research

It’s time to make ClinicalTrials.gov a better tool for patients - STAT | 4/28/2020

… all say, ClinicalTrials.gov is not an easy website to use. Trial designs are confusing to users who aren’t familiar with clinical research. And inclusion and exclusion criteria, as well as outcome measures, often read as … a fact recognized and endorsed by the FDA and the National Institutes of Health. The FDA uses it as its chief patient search tool under “ Clinical Trials: What Patients Need to Know ,” and the NIH …

American Association for Cancer Research

AACR: A look at next-gen CAR-T therapies for blood cancers | FierceBiotech | 4/27/2020

… working on those wrinkles, though, and some early data that sketch out possible solutions will be presented virtually at the American Association for Cancer Research (AACR) this week . The first set of data, featuring a … a bid to ward off relapse. The investigators, from the National Institutes of Health and the University of Colorado, tested three doses of a bispecific CAR-T in 11 children and young adults with B …

AACR

AACR: A look at next-gen CAR-T therapies for blood cancers | FierceBiotech | 4/27/2020

… and some early data that sketch out possible solutions will be presented virtually at the American Association for Cancer Research (AACR) this week . The first set of data, featuring a CAR-T treatment made from … a bid to ward off relapse. The investigators, from the National Institutes of Health and the University of Colorado, tested three doses of a bispecific CAR-T in 11 children and young adults with B …

Medicare

White House weighing plan to replace Azar | 4/26/2020

… with the discussions. Among the names on the short list to replace Azar are White House coronavirus coordinator Deborah Birx, Medicare chief Seema Verma and deputy HHS Secretary Eric Hargan, said the four people familiar … assured Vice President Mike Pence that Bright’s move to the National Institutes of Health was a promotion — only for Bright and his lawyers to release a statement that he would soon file a whistleblower complaint …

Regenerative Medicine

Outlook on the Worldwide Tissue Engineering Industry to 2027 - Growth in the Global Healthcare Market Presents Opportunities | Globe Newswire | 4/24/2020

National Institutes of Health (NIH) funding study in the US, the research studies pertaining to stem cell and regenerative medicines received funding of USD 1.8 billion and USD 1.0 billion, respectively, in 2018.The global tissue engineering market is segmented into material type and application. The tissue engineering market, by material type, is further segmented into synthetic material, biologically derived materials, and others. The biologically derived materials segment held the …

American Medical Association

A slew of new studies are raising fresh doubts on whether malaria pills should be used to treat the coronavirus, and a top US health agency just warned against widespread use | Business Insider | 4/24/2020

… spike in deaths among patients who received the drug. The Brazilian trial, published on Friday in the Journal of the American Medical Association Network Open, added to a pile of confusing evidence around using the … or at hospital because of safety risks to patients. The National Institutes of Health has advised caution in prescribing them. New York Gov. Andrew Cuomo said Thursday night that a review of medical records by …

Patient Safety

Science 37® Partners with Advarra to Expedite Virtual Trial Research for COVID-19 | PR Newswire | 4/21/2020

… with COVID-19 protocols and provides priority review for these studies, can help sponsors make the necessary adjustments to ensure patient safety.” The virtual research model has become the standard of clinical research in the … IBC-ready model that can help sites register with the National Institutes of Health and reduce start-up time. These capabilities, when combined with the proprietary platform and virtual trial expertise of Science 37, enable …

GlaxoSmithKline

Identification and Characterization of a Potential Therapeutic COVID-19 Antibody by Vir Biotechnology Published in Nature | Globe Newswire | 5/18/2020

… candidates based on the S309 antibody as potential therapeutics for COVID-19, VIR-7831 and VIR-7832, in collaboration with GlaxoSmithKline plc (LSE/NYSE: GSK). “Remarkably, we believe S309 likely covers the entire family of … that was isolated by Vir scientists in collaboration with the National Institutes of Health (NIH) and other government agencies using the same approach used to discover and develop S309. mAb114 is being developed by Ridgeback …

GSK

Identification and Characterization of a Potential Therapeutic COVID-19 Antibody by Vir Biotechnology Published in Nature | Globe Newswire | 5/18/2020

… CoV-2 and related viruses, suggesting high barrier to resistance Clinical testing expected to begin this summer in collaboration with GSK SAN FRANCISCO, Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the publication of research findings … that was isolated by Vir scientists in collaboration with the National Institutes of Health (NIH) and other government agencies using the same approach used to discover and develop S309. mAb114 is being developed by Ridgeback …

Inovio

To take on the coronavirus, US vaccine makers consider an unprecedented strategy: working together - CNN | 5/13/2020

… members of the Accelerating Covid-19 Therapeutic Interventions and Vaccines group, or ACTIV , which was organized last month by the National Institutes of Health. The second, they said, involves several vaccine developers working in one … Pfizer is working with German company BioNTech, and Pennsylvania-based Inovio is also in clinical trials. He signed up for a coronavirus vaccine trial using a method that’s never been used in humans. Here’s why …

Pfizer

How researchers had a head start on a coronavirus vaccine | 5/12/2020

Inside the race to find a coronavirus vaccine Last Updated May 12, 2020 9:44 AM EDT More than 100 potential coronavirus vaccines are being tested at record speeds. Drugmaker Moderna got FDA approval last week to start a second round of clinical trials and Pfizer began human trials of its vaccine candidate in the U.S. Kizzmekia Corbett, who leads the National Institutes of Health coronavirus vaccine collaboration with Moderna, told …

Spark Therapeutics

Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases | PR Newswire | 5/12/2020

… manufacturing infrastructure – Partnerships in place with leading academic and research institutions, including Universitat Autònoma de Barcelona (UAB) and the U.S. National Institutes of Health (NIH) News provided by May 12, 2020, 07:45 ET Share this … leading gene therapy team that includes former senior leadership from Spark Therapeutics, AveXis, Sangamo Therapeutics, and other gene therapy companies. Kriya’s pipeline today includes multiple AAV-based gene therapies for the treatment of type 1 …

AveXis

Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases | PR Newswire | 5/12/2020

… manufacturing infrastructure – Partnerships in place with leading academic and research institutions, including Universitat Autònoma de Barcelona (UAB) and the U.S. National Institutes of Health (NIH) News provided by May 12, 2020, 07:45 ET Share this … therapy team that includes former senior leadership from Spark Therapeutics, AveXis, Sangamo Therapeutics, and other gene therapy companies. Kriya’s pipeline today includes multiple AAV-based gene therapies for the treatment of type 1 and type …

Gilead Sciences

ICYMI: Top takeaways from this week’s “Face the Nation” | CBS News | 5/4/2020

… new hope for an eventual end to COVID-19 was ignited this week. A recently completed study led by the National Institutes of Health found that remdesivir shortened the recovery time for some coronavirus patients … Who gets it? With an emergency use authorization in hand, Gilead Sciences CEO Daniel O’Day said supplies of remdesivir will be sent out to the most severe patients at the “early part of this next …

WebMD

Can Early Exposure Fix Food Allergies? | WebMD | 4/29/2020

… Learning Early About Peanut allergy) were published in The New England Journal of Medicine . (The study is supported by the National Institutes of Health and the Immune Tolerance Network.) It revealed how early exposure to … articles, browse back issues, and read the current issue of WebMD Magazine . WebMD Magazine - Feature Reviewed by Jennifer Robinson, MD on April 19, 2020 Sources SOURCES: Maria Garcia-Lloret, MD, associate professor of pediatrics, division …

Boston Scientific

COVID-19 ‘Therapies’ Put Focus on 12-Lead ECG Alternatives | WebMD | 4/29/2020

… QTc-Prolonging Potential As stated by US government bodies such as the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH), “There are insufficient clinical data to recommend either for or … more important. Ackerman has consulted for Abbott, Audentes Therapeutics, Biotronik, Boston Scientific, Daiichi Sankyo, Gilead Sciences, Invitae, LQT Therapeutics, Medtronic, MyoKardia, and UpToDate; Ackerman and the Mayo Clinic have a royalty agreement with AliveCor, and …

Boehringer Ingelheim

COVID-19 ‘Therapies’ Put Focus on 12-Lead ECG Alternatives | WebMD | 4/29/2020

… QTc-Prolonging Potential As stated by US government bodies such as the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH), “There are insufficient clinical data to recommend either for or … for Biosense Webster, sanofi-aventis, MRI Interventions, Bristol-Myers Squibb, Boehringer Ingelheim, Biotronik, Ecardio, St. Jude Medical, Medtronic, Arapeen, MARREK, Daiichi Sankyo, Cardiac Designs, and VytronUs and receiving research grants from MRI Interventions, Sanofi, Biosense …

Medtronic

COVID-19 ‘Therapies’ Put Focus on 12-Lead ECG Alternatives | 4/29/2020

… QTc-Prolonging Potential As stated by US government bodies such as the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH), “There are insufficient clinical data to recommend either for or … Biotronik, Boston Scientific, Daiichi Sankyo, Gilead Sciences, Invitae, LQT Therapeutics, Medtronic, MyoKardia, and UpToDate; Ackerman and the Mayo Clinic have a royalty agreement with AliveCor, and the Mayo Clinic has equity interest in the company …

Quest Diagnostics

Gilead’s coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug (GILD) | Business Insider | 4/29/2020

… 1,000 hospitalized patients found those taking the antiviral drug remdesivir recovered 31% faster than those taking a placebo, the US National Institutes of Health said Wednesday. That means the typical COVID-19 patient taking remdesivir … the Ebola outbreak in the hunt for a coronavirus cure Quest Diagnostics is rolling out the first coronavirus antibody test you can order online. Here’s how you can get one …

Novartis

Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer | PR Newswire | 4/27/2020

… European Medical Director, based in Munich, Germany and Global Medical Lead - Acute Cardiovascular Care at The Medicines Company, acquired by Novartis AG this year. Most recently Dr. Deliargyris was Chief Medical Officer of PLx Pharma … Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM), the U.S. Army, U.S. Special Operations Command (USSOCOM …

Apple Health

5 things for CISOs to know during COVID-19 pandemic | Becker’s Hospital Review | 4/27/2020

… National Institutes of Health, World Health Organization, Gates Foundation and others working to fight the COVID-19 pandemic. Various hate groups published the information to online messaging boards and lists, including Twitter, 4chan and Pastebin. 2. Apple iPhones contain a flaw in the email software that makes the devices more vulnerable to cyber hackers. Because of the flaw, hackers can send an email that triggers a bug when the iPhone …

LabCorp

Another Navy warship at sea reports a coronavirus outbreak | Chron | 4/24/2020

Close Image 1 of 3 FILE - This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. Also known as 2019-nCoV … will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S. (NIAID-RML via AP) less FILE - This undated electron microscope image made available by the U.S. National …

Novo Nordisk

Coronavirus tracker: Ex-HHS vaccine official turns COVID-19 whistleblower; Lilly sales rise on pandemic stock-ups | FiercePharma | 4/23/2020

… 6 inhibitor Actemra, which has shown some early effect in treating cytokine storm in severe COVID-19 patients. Meanwhile, the National Institutes of Health has kicked off a “Shark Tank”-style effort to fund new … Tuesday investor note. Following other companies such as Pfizer and Novo Nordisk, Merck & Co. is now also expanding its patient assistance program, allowing eligible patients to get its medicines at no cost. To ease shortages …

Novavax

BARDA loses leader in middle of race to create COVID-19 vaccine | FierceBiotech | 4/22/2020

… against COVID-19 has lost its leader. Rick Bright, a vaccine specialist, is moving to a new role in the National Institutes of Health (NIH) at a time when his former employer is scrambling to … flu pandemic preparations and working on vaccine R&D at Novavax on his résumé. Yet, as Stat first reported , Bright has now left BARDA. Bright has moved over to a role at the NIH that …

AbbVie

IMBRUVICA® (ibrutinib) Receives 11th FDA Approval | PR Newswire | 4/21/2020

NORTH CHICAGO, Ill. , April 21, AbbVie (NYSE: ABBV ), a research-based global biopharmaceutical company, today announced that the U.S. (FDA) approved the use of IMBRUVICA ® (ibrutinib) in combination with rituximab for the treatment of previously … sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). This is the third Phase 3 randomized study in the treatment of previously untreated CLL patients incorporated into the medicine’s …

Merck

NY pharma titans join federal agencies to speed treatment, vaccine work | 4/20/2020

… the public-private partnership, called ACTIV, to prioritize vaccine and drug candidates, streamline clinical trials and coordinate regulatory processes, the National Institutes of Health said Friday. The goal is to more rapidly and collectively respond … New Brunswick, N.J.-based Johnson & Johnson and Kenilworth, N.J.-based Merck. Along with the NIH, the government partners are the Department of Health and Human Services, the Food and Drug Administration, the Centers for Disease …

Qiagen

Genomics Industry Review 2015-2019 and Opportunity Outlook 2020-2030 | 4/17/2020

… and private institutions. For instance, in 2018, in the U.S, The All of Us Research Program, a part of the National Institutes of Health, gave funds of $28.6 million for establishing three genome centers in … for cancer. Major players in the market are 10X Genomics, Qiagen, Fluidigm Corporation, Johnson & Johnson, Zephyrus Biosciences, Illumina, Affymetrix, Angle, Denovo Sciences and Diagnologix LLC. Key Topics Covered 1. Executive Summary 2. Genomics Market Characteristics …

Thermo Fisher

Genomics Industry Review 2015-2019 and Opportunity Outlook 2020-2030 | PR Newswire | 4/17/2020

… and private institutions. For instance, in 2018, in the U.S, The All of Us Research Program, a part of the National Institutes of Health, gave funds of $28.6 million for establishing three genome centers in … Private Limited Kellbenx Inc. Qiagen N.V. Resolution Bio Science Inc. Thermo Fisher Scientific Inc. Wafergen Bio-systems Inc. Yikon Genomics Co. Ltd. Zephyrus Biosciences Inc. For more information about this report visit https://www.researchandmarkets.com/r …

Allergan

Reprogrammed skin cells restore sight in mouse models of retinal disease | FierceBiotech | 4/15/2020

… Many attempts to restore light-sensing cells have involved coaxing stem cells to become photoreceptors. Now, researchers led by the National Institutes of Health’s National Eye Institute (NEI) have developed a new technique that they … therapy that treats an inherited form of blindness. Editas and Allergan recently kicked off a clinical trial of a treatment that uses the gene editing system CRISPR to correct sight loss caused by mutations in …

Microsoft Health

Andor Health Platform to Accelerate Clinical Research Team Collaboration and Communication at National Institutes of Health | PR Newswire | 4/8/2020

ORLANDO, Fla. Andor Health announces that the National Institutes of Health (NIH) Clinical Center will deploy the ThinkAndor™ mobile platform to improve overall clinical research team collaboration and communication. The NIH Clinical Center is one … collaboration across the care continuum. ThinkAndor is natively integrated with Microsoft ® Teams , providing an integrated collaboration toolset for sharing documents, and conducting persistent chat conversations and clinician meetings with audio, video, screen sharing, recording and …

Amazon Health

Microsoft lends petaflops to ImmunityBio’s coronavirus protein modeling efforts | FierceBiotech | 4/1/2020

… and infect human cells. Previous digital blueprints of the protein have already been provided to the research community by the National Institutes of Health and the University of Texas, with the use of cryo-electron … coronavirus,” Patrick Soon-Shiong, chairman and CEO of ImmunityBio. RELATED: Amazon, Microsoft launch initiatives to accelerate COVID-19 research and testing “Structures of this complex are available but understanding how the two proteins dynamically interact …

Gilead

Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis | PR Newswire | 3/23/2020

… catalyzed the development of novel vaccines across the biotech industry, both by pharmaceutical companies and research organizations such as the National Institutes of Health (NIH), U.S. Some are taking a cue from older antivirals. Some … CNSP ), Sorrento Therapeutics, Inc. (NASDAQ: SRNE ), Moderna, Inc. (NASDAQ: MRNA ), Gilead Sciences, Inc. (NASDAQ: GILD ), Inovio Pharmaceuticals, Inc. (NASDAQ: INO ). Health officials from WHO have noted that Gilead’s remdesivir has demonstrated efficacy in treating the …

Foresite Capital

Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases | PR Newswire | 5/12/2020

… manufacturing infrastructure – Partnerships in place with leading academic and research institutions, including Universitat Autònoma de Barcelona (UAB) and the U.S. National Institutes of Health (NIH) News provided by May 12, 2020, 07:45 ET Share this … and industry pioneers. Series A investors include QVT, Dexcel Pharma, Foresite Capital, Bluebird Ventures (associated with Sutter Hill Ventures), Narya Capital, Amplo, Paul Manning , and Asia Alpha . This Series A round follows an initial seed …

Morgan Stanley

Live updates on COVID-19: April 1-15 | 5/5/2020

… every shift. Several local news outlets also believe some states are undercounting the number of people succumbing to the disease. Morgan Stanley’s estimates on outbreak recovery Morgan Stanley: “While we understand the desire for optimism … time under surgical masks and other personal protective equipment, the National Institutes of Health are trying to make that time more comfortable. NIH released a 3D printed template for a tension release band healthcare workers …

NCI

Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells | BMJ | 4/3/2020

… by the European Regional Development Fund of the European Union) and PROMETEO2018/141 (from Conselleria d’Educació, Investigació, Cultura i Esport, Generalitat Valenciana). AM-R and ÁBM are recipients of Predoctoral Trainee Research Grants (FPU13/00151 and FPU16/05896 … Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Disclaimer The contents of this publication are solely the responsibility of the authors and …

Rock Health

Biotech innovations to spur next phase of personalized care | Modern Healthcare | 3/28/2020

… we could be at that point.” The targeting of biotech has been driven by continued interest from agencies like HHS’ National Institutes of Health , as well as investors who have poured millions into the space … for Digital Health and early-stage digital health venture fund Rock Health. While most of those devices track more general exercise, sleep and heart rate, and aren’t used for medical care, they could point to …

Goldman Sachs

Tech’s coveted internships are getting canceled due to COVID-19 | TechCrunch | 3/25/2020

Goldman Sachs to pursue a software engineering position. The offer they accepted was yanked weeks later. Another student lost their chance at a post-graduate job at their dream company because their offer was revoked. One only had an offer in their hands for three weeks before it was rescinded. A number of companies across the country, including Google, Glassdoor, StubHub, Funding Circle, Yelp , Checkr and even the National Institutes …

Bill & Melinda Gates Foundation

Gates-funded program will soon offer home-testing kits for new coronavirus | Modern Healthcare | 3/9/2020

Print AP This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange, emerging from the surface of cells, gray, cultured … day, said Scott Dowell, leader of coronavirus response at the Bill & Melinda Gates Foundation. The project is ramping up as quickly as possible, but it’s not clear exactly when it will launch, he added. Among …

Silicon Valley Bank

AiCure’s strategy of providing data for life sciences reinforced by record economic momentum | PR Newswire | 1/14/2020

Silicon Valley Bank (SVB) and the National Institutes of Health (NIH) Increased worldwide patent portfolio to 67 issued and allowed patents and 110 filed. Examples of industry accolades include: Ranked by CB Insights in the 2019 Digital Health 150 Listed among PM360’s Most Innovative Companies Ranked in the 10 Health Tech Companies to Watch in 2019 by Socialnomics Artificial Intelligence and Platform Milestones Greatly enhanced the AiCure data and …

Atlas Venture

Opinion: Innovation in biotech R&D: New resources offer new hope | STAT | 1/14/2020

… as always, is the federal government. Two years ago, Jeffrey Bluestone, Laurie Glimcher, and I argued in STAT that the National Institutes of Health risked losing its edge in biomedical innovation. Since then, the landscape … R&D. In this environment, philanthropists and firms like ARCH, Atlas Venture, Deerfield, RA Capital, Third Rock, Venrock, and others are creating startups directly from university spinouts. The most intriguing advance might be the possibility …

C-Bridge Capital

Global Hematology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | PR Newswire | 12/4/2019

… of America Blood Systems Bluebird Bio BMG Pharmaceuticals Bonfils Blood Center Boryung Pharmaceutical Bristol- Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome … Foundation National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics …

Wellcome Trust

Orchestrating single-cell analysis with Bioconductor | Nature | 12/2/2019

… references Acknowledgements Bioconductor is supported by the National Human Genome Research Institute (NHGRI) and National Cancer Institute (NCI) of the National Institutes of Health (NIH) (grant no. U41HG004059, U24CA180996), the European Union (EU) H2020 Personalizing … ATLL received support from CRUK (grant no. A17179) and the Wellcome Trust (grant no. WT/108437/Z/15). F.M. is supported by the German Federal Ministry of Education and Research (grant no. BMBF 01EO1003). M.L.S …

Lincoln Park Capital Fund

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

Lincoln Park Capital Fund Lonza The University of Texas MD Anderson Cancer Center Mallinckrodt Pharmaceuticals Marina Biotech Massachusetts Institute of Technology Medison Pharma miRagen Therapeutics miReven MirImmune Mirimus Moderna Therapeutics Moore Venture Partners MP Healthcare Venture Management MRL Ventures Fund (MRLV) Nant Capital NantVentures National Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC …

HealthCare Ventures

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… Pharma miRagen Therapeutics miReven MirImmune Mirimus Moderna Therapeutics Moore Venture Partners MP Healthcare Venture Management MRL Ventures Fund (MRLV) Nant Capital NantVentures National Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore Biopharma OriGene Technologies Oxford Finance Partner Fund Management PCI Biotech Pfizer Phio …

Bain Capital

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… Institute of Molecular and Cell Biology (IMCB), A STAR Atlas Venture AUM LifeTech Avecia Biotechnology Avidity Biosciences Axovant Gene Therapies Bain Capital Life Sciences Benitec Biopharma Biogen Biomics Biotechnologies (a GE Unit) Bioneer BioNTech Biosettia … Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore …

Domain Associates

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… Management Covance Covidien CR-CP Life Science Fund Creative Animodel Creative Biogene CureDuchenne Dana-Farber Cancer Institute Dharmacon Dicerna Pharmaceuticals Domain Associates EcoR1 Capital Eli Lilly Eurofins Genomics Eurogentec Exiqon Fidelity Biosciences FOCUS Media Jiangnanchun … Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore …

F-Prime Capital

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… Institute Dharmacon Dicerna Pharmaceuticals Domain Associates EcoR1 Capital Eli Lilly Eurofins Genomics Eurogentec Exiqon Fidelity Biosciences FOCUS Media Jiangnanchun Foundation F-Prime Capital GeneCopoeia GeneCust GeneDesign GENEL Genentech GenePharma Genesis Pharmaceuticals Sanofi Genzyme / Genzyme Genomics … Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore …

Amgen Ventures

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

… Therapeutics Aglaia Oncology Fund II Alcobra Alethea Capital Management Alexandria Real Estate Equities Alexion Pharmaceuticals Alnylam Pharmaceuticals Altogen Labs Amgen Amgen Ventures AMSBIO Arbutus Biopharma (previously Tekmira) ARIZ Precision Medicine Arrowhead Pharmaceuticals Ascletis Pharma Asklepios … Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS), National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore …

RA Capital Management

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

National Institutes of Health National Institutes of Health National Health and Medical Research Council (NHMRC) Nitto Denko Novartis Novozymes Oligoengine OliX Pharmaceuticals Omnia Biologics OnCore Biopharma OriGene Technologies Oxford Finance Partner Fund Management PCI Biotech Pfizer Phio Pharmaceuticals (previously known as Rxi Pharmaceuticals) Phyzat Biopharmaceuticals QIAGEN QianHai Fund of Funds Qianhai Shenghui Investment Quark Pharmaceuticals RA Capital Management Radboud University Regen BioPharma Regeneron Pharmaceuticals Regulus Therapeutics Remeditex Ventures ReNeuron RiboBio …

Deerfield Management

Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2019 Financial Results | Business & Finance | heraldchronicle.com | Business Wire | 11/18/2019

… Financing (July 2019) : The Company completed a $62 million private financing led by Perceptive Advisors and a syndicate that included Deerfield Management, RTW Investments, and Mizuho Securities Principal Investment. License and Collaboration Agreement with Astellas … hearing loss from recreational noise exposure. According to the U.S. National Institutes of Health, more than 90 percent of those with hearing loss are affected by SNHL. About Frequency Therapeutics Frequency Therapeutics is a leader …

Johnson & Johnson Innovation

Children’s National Hospital, Virginia Tech Announce Partnership for New Children’s National Research & Innovation Campus | PR Newswire | 11/14/2019

… treatment and cures to save children’s lives.” B-Roll and Soundbites Earlier this year, Children’s National announced a collaboration with Johnson & Johnson Innovation LLC to launch JLABS @ Washington, DC at the Research & Innovation Campus. The … you create a hotbed for innovation.” Ranked 7 th in National Institutes of Health research funding among pediatric hospitals, Children’s National continues to foster collaborations as it prepares to open its first 158,000-square-foot …

Andreessen Horowitz

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 2 of 4 - Saama Technologies | 11/13/2019

… FDA and PMDA. Dr. Kush has over 30 years of experience in clinical research, including positions with academia, the U.S. National Institutes of Health, a global CRO and biopharmaceutical companies in the U.S. and Japan … Complia Health. He is currently a Special Advisor to both Andreessen Horowitz Venture Capital Firm and Carrick Capital Partners Private Equity Firm. He is also an advisor at Pinterest as well as several other early …

New Enterprise Associates

It’s tiny biotechs — not big drug makers — that fear ‘nuclear winter’ from Pelosi’s drug pricing bill | STAT | 11/12/2019

… companies, according to data from BIO. The modern drug development process goes like this: A discovery is made at the National Institutes of Health or in an academic lab, small biotech entrepreneurs spin the idea … Dr. Sara Nayeem, a partner at the venture capital firm New Enterprise Associates. “It’s a bit frightening actually to see the specter of just a complete blunt instrument dampening innovation that may have a short …

5AM Ventures

Scientist.com Recognized as One of North America’s Fastest-Growing Companies by Deloitte | Business & Finance | manchestertimes.com | Business Wire | 11/12/2019

National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit scientist.com to learn more. View source version on businesswire.com : https://www.businesswire.com/news/home/20191112005392/en/ CONTACT: Sean Preci +1 858 455-1300 ext. 401 KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: RESEARCH TECHNOLOGY OTHER TECHNOLOGY NETWORKS BIOTECHNOLOGY INTERNET GENERAL HEALTH PHARMACEUTICAL HEALTH …

Leerink Transformation Partners

Scientist.com Recognized as One of North America’s Fastest-Growing Companies by Deloitte | Business & Finance | manchestertimes.com | Business Wire | 11/12/2019

National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit scientist.com to learn more. View source version on businesswire.com : https://www.businesswire.com/news/home/20191112005392/en/ CONTACT: Sean Preci +1 858 455-1300 ext. 401 KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: RESEARCH TECHNOLOGY OTHER TECHNOLOGY NETWORKS BIOTECHNOLOGY INTERNET GENERAL HEALTH PHARMACEUTICAL HEALTH …

Leerink Partners

Scientist.com Recognized as One of North America’s Fastest-Growing Companies by Deloitte | Business & Finance | manchestertimes.com | Business Wire | 11/12/2019

… reducing risk and providing access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit scientist.com to learn more. View source version on businesswire.com …

Maxim Group

Navidea Biopharmaceuticals’ (NAVB) CEO Jed Latkin on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/9/2019

… Chief Executive Officer Mike Rosol – Chief Medical Officer Erika Gibs – Director of Finance and Administration Conference Call Participants Jason McCarthy – Maxim Group Rick Drew – Private Investor Jed Latkin Good afternoon, and welcome, everyone, to Navidea’s … revenue related to small business innovation research grants from the National Institutes of Health supporting development. Research and development expenses for the third quarter of 2019 were $1.8 million compared to $1.2 million in the …

Kaiser Permanente

Dispensed: How healthcare is forever changed — a vaccine by fall — reopening the office | 5/15/2020

… of a potential vaccine for COVID-19, the disease caused by the new coronavirus Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. AP Photo/Ted S. Warren Samantha Lee … businessinsider.com if you would like to send along your observations. National Institutes of Health Director Dr. Francis Collins speaks during a Senate Health Education Labor and Pensions Committee hearing on new coronavirus disease (COVID-19 …

Boston Children's Hospital

Coronavirus “can become very severe” in kids, mom says | CBS News | 5/5/2020

The National Institutes of Health is launching a study to learn more about how the coronavirus affects children . While most kids have milder symptoms than adults, not all do. Karla Duarte, a 16-year-old … Randolph, who is leading a separate CDC-funded study at Boston Children’s Hospital, said doctors aren’t completely sure what the risk factors are for why children get sick with COVID-19. Describing the symptoms seen …

Mount Sinai Hospital

Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage Shigella Infections in Humans | PR Newswire | 5/4/2020

… that it has received a multimillion-dollar grant (AI 148054) from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), for the clinical development of its bacteriophage therapy preparation for … worldwide. Intralytix is currently sponsoring a clinical trial at the Mount Sinai Hospital in New York , for which it is IND-holder ( https://clinicaltrials.gov/ct2/show/NCT03808103?term=Intralytix&rank=1 ), and the Company also …

Mayo Clinic

Trump expects coronavirus vaccine by year’s end — here’s why that’s unlikely | 5/4/2020

… Mayo Clinic’s Vaccine Research Group, to help unpack the process, and clarify why earning vaccine approval is deliberately difficult. Vaccine development requires funding, then rigorous clinical trials Poland says the process begins with “pre-clinical work,” which requires securing funding — either from the National Institutes of Health or another investor — followed by “small-animal testing” studies. After these are completed, researchers can submit for FDA approval to begin human testing …

Boston Medical Center

Critical study of Gilead drug shows coronavirus patients responding to treatment, NIH says | 4/30/2020

… worldwide. During an appearance alongside President Trump in the Oval Office, Anthony Fauci, the director of NIAID, part of the National Institutes of Health, said the data are a “very important proof of concept” and … Nahid Bhadelia, medical director of the special pathogens unit at Boston Medical Center. “We know that with most antiviral medications the earlier you give it the better it is.” said Bhadelia, who had experience giving …

Memorial Sloan Kettering

Critical study of Gilead drug shows coronavirus patients responding to treatment, NIH says | 4/30/2020

… worldwide. During an appearance alongside President Trump in the Oval Office, Anthony Fauci, the director of NIAID, part of the National Institutes of Health, said the data are a “very important proof of concept” and … director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Medical Center, said he is eager to see the data from the NIAID study but renewed his criticism of Gilead’s severe study …

Massachusetts General Hospital

Company says drug proved effective against virus in US study | Star Tribune | 4/29/2020

… from the partial results revealed so far. “What it has proven is that a drug can block this virus,” the National Institutes of Health’s Dr. Anthony Fauci said. “This will be the standard of care … Elizabeth Hohmann, who enrolled 49 patients in the experiment at Massachusetts General Hospital, said study leaders were told Tuesday night that the results are based on “the first cut of 460 patients.” “There’s over 1,000 …

Banner Health

5 things for CISOs to know during COVID-19 pandemic | Becker’s Hospital Review | 4/27/2020

… Here are five things for CISOs to know: 1. Hackers posted nearly 25,000 email addresses and passwords belonging to the National Institutes of Health, World Health Organization, Gates Foundation and others working to fight the … million settlement to end claims from a 2016 Phoenix-based Banner Health data breach that exposed personal information of 2.9 million patients. The settlement will pay $500 to each patient who is covered by the …

Cleveland Clinic

The Latest: Surgeon says daily evaluation of changes needed - The Mercury News | 4/25/2020

… prove whether any of the drugs being explored as COVID-19 treatments actually work. Fauci, infectious diseases chief at the National Institutes of Health, said Saturday during an online meeting of the National Academy of … that we’ve had put in place,” said Barsoum, president of Cleveland Clinic Florida. “But please recognize that we will learn every day, and we may have to step back from some of those decisions as …

Cleveland Clinic, Cleveland OH

The Latest: Surgeon says daily evaluation of changes needed - The Mercury News | 4/25/2020

… prove whether any of the drugs being explored as COVID-19 treatments actually work. Fauci, infectious diseases chief at the National Institutes of Health, said Saturday during an online meeting of the National Academy of … that we’ve had put in place,” said Barsoum, president of Cleveland Clinic Florida. “But please recognize that we will learn every day, and we may have to step back from some of those decisions as …

Indiana University School of Medicine

Very low-dose Avastin effective for preventing blindness in preterm infants | National Institutes of Health | 4/23/2020

… conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and supported by the National Eye Institute (NEI), part of the National Institutes of Health. Preterm babies are at high risk of abnormal blood vessel growth … chair, David Wallace, M.D., MPH, chair of ophthalmology at the Indiana University School of Medicine. Laser therapy requires sedating the baby for as long as 90 minutes; an Avastin injection takes much less time and …

Mount Sinai Health System

New analysis recommends less reliance on ventilators to treat coronavirus patients | STAT | 4/21/2020

… for when to use ventilators for Covid-19 patients — a message consistent with new treatment guidelines issued Tuesday by the National Institutes of Health, which advocates a phased approach to breathing support that would defer … stories of the day. Privacy Policy Earlier this month, the Mount Sinai Health System in New York developed a protocol to repurpose sleep apnea machines for Covid-19 patients, while in Rhode Island, the Department …

Sinai Health System

New analysis recommends less reliance on ventilators to treat coronavirus patients | STAT | 4/21/2020

… for when to use ventilators for Covid-19 patients — a message consistent with new treatment guidelines issued Tuesday by the National Institutes of Health, which advocates a phased approach to breathing support that would defer … of the day. Privacy Policy Earlier this month, the Mount Sinai Health System in New York developed a protocol to repurpose sleep apnea machines for Covid-19 patients, while in Rhode Island, the Department of …

Harvard Medical School

New analysis recommends less reliance on ventilators to treat coronavirus patients | 4/21/2020

… for when to use ventilators for Covid-19 patients — a message consistent with new treatment guidelines issued Tuesday by the National Institutes of Health, which advocates a phased approach to breathing support that would defer … that I’ve seen,” said palliative care physician Muriel Gillick of Harvard Medical School, who was one of the first to ask if ventilators were harming some Covid-19 patients, especially elderly ones. “There is mounting …

Northwell Health

NY pharma titans join federal agencies to speed treatment, vaccine work | Crain’s New York Business | 4/20/2020

… the public-private partnership, called ACTIV, to prioritize vaccine and drug candidates, streamline clinical trials and coordinate regulatory processes, the National Institutes of Health said Friday. The goal is to more rapidly and collectively respond … not delivered medical supplies ordered by consumers. SOCIAL CHAT BOT: Northwell Health said it is using its artificial intelligence-based chat-bot platform, Conversa, to help with virus-related concerns. It’s using the conversation technology …

University of Chicago Medical Center

COVID-19: New animal data back up Gilead’s remdesivir as other treatment candidates emerge | FierceBiotech | 4/20/2020

… D amid questions about whether early human trials of the drug have adequately proven it works. Now, scientists at the National Institutes of Health and Gilead have published results from an animal trial of remdesivir … trial of the drug in COVID-19 patients at the University of Chicago Medical Center were leaked . Problem is, no one will be able to say for certain whether remdesivir will be the panacea everyone …

Rush University Medical Center

COVID-19 offers opportunity for more equality in healthcare | 4/18/2020

… some of those gaps. Health system leaders should take note of this development—and nurture it. As the chair of Rush University Medical Center’s Women’s Leadership Council and a member of our Diversity Leadership Council … they’re paid less than their male counterparts, receive less in National Institutes of Health grant funding, and are significantly less likely to hold first and senior authorship positions. But crises have the power to level …

Stanford Medicine

Stanford Medicine tests anti-viral drug for COVID-19 | News Center | Stanford Medicine | 4/17/2020

With no approved treatments for COVID-19, Stanford Medicine has joined large-scale clinical trials to determine if remdesivir, an experimental anti-viral medication, works. Apr 17 2020 Philip Grant and Aruna Subramanian, practicing proper … scale clinical trial of remdesivir, this one sponsored by the National Institutes of Health . “We brought this on fast,” said Aruna Subramanian , MD, clinical professor of infectious disease and co-principal investigator of the Gilead …

Stanford Health Care

Stanford Medicine tests anti-viral drug for COVID-19 | News Center | Stanford Medicine | 4/17/2020

… of Stanford scientists began enrolling participants in a similar, large-scale clinical trial of remdesivir, this one sponsored by the National Institutes of Health . “We brought this on fast,” said Aruna Subramanian , MD, clinical professor … care at its three institutions - Stanford University School of Medicine , Stanford Health Care (formerly Stanford Hospital & Clinics) , and Lucile Packard Children’s Hospital Stanford . For more information, please visit the Office of Communication & Public Affairs site …

Stanford Health Care, Stanford CA

Stanford Medicine tests anti-viral drug for COVID-19 | News Center | Stanford Medicine | 4/17/2020

… of Stanford scientists began enrolling participants in a similar, large-scale clinical trial of remdesivir, this one sponsored by the National Institutes of Health . “We brought this on fast,” said Aruna Subramanian , MD, clinical professor … care at its three institutions - Stanford University School of Medicine , Stanford Health Care (formerly Stanford Hospital & Clinics) , and Lucile Packard Children’s Hospital Stanford . For more information, please visit the Office of Communication & Public Affairs site …

Walter Reed National Military Medical Center

Covid-19 exposes vulnerabilities in D.C. region’s … | The Washington Post | 4/13/2020

… National Institutes of Health, Walter Reed National Military Medical Center, Johns Hopkins University School of Medicine and a growing biotech industry. One source of weakness has been budget cuts at the region’s public health agencies, which form a first line of defense against epidemics. The cuts started with the 2008 recession and were never fully restored. AD The health departments of Maryland, Virginia and the District reduced staff by a …

Providence Health

President Trump is wrong in so many ways about hydroxychloroquine studies. Here are the facts - CNN | 4/11/2020

… have an effect. Read More CDC removes guidance on drugs touted by Trump to treat coronavirus CNN searched clinicaltrials.gov , the National Institutes of Health database of privately and publicly funded clinical studies around the world … Utah ; the University of Pennsylvania ; Washington University in St. Louis; Providence Health in Oregon; ProgenaBiome , a laboratory in California and Sanofi , a pharmaceutical company. Question 2: French researchers have already done a clinical study showing …

UW Medicine

Building ‘Mission Essential Infrastructure’ for COVID-19 Response | Markets Insider | Business Insider | 4/9/2020

National Institutes of Health (NIH), Massachusetts General Hospital, Stanford Health Care, Kaiser Permanente, UW Medicine, Yale New Haven Health, and the US Department of Veterans Affairs (VA). This experience positions Germfree to provide what is needed today as well as solutions that can be easily tailored in the future to meet needs that have yet to be identified. “While not endorsing any particular company or product, rapidly deployable, complete laboratories …

Montefiore Health System

Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein | PR Newswire | 4/3/2020

BRONX, N.Y. , April 3, Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial. This treatment has the potential to help people who have serious lung complications as a …

Columbia University Medical Center

The top 10 medical schools, according to US News & World Report | CNBC | 4/1/2020

… 189 accredited medical programs and considered a wide range of factors, including peer assessments and medical research funding from the National Institutes of Health, to calculate its rankings. Here are the top 10 medical programs … Total enrollment: 489 A general view of the exterior of Columbia University Medical Center at NewYork-Presbyterian Hospital in New York City. Getty Images 6. Columbia University (tie) Overall score: 72 Peer assessment score (1-5 …

Aetna

Calculating the Costs of Clinical Trials | 12/1/2019

… the hidden costs of trial participation Of the three potential risks of participating in a clinical trial listed on the National Institutes of Health (NIH) website, two are related to the potential costs, hidden and … and established standards of care for a particular diagnosis.” 5 Aetna’s website stipulates that “all applicable plan limitations for coverage of out-of-network care will apply to routine care costs in clinical trials.” 6 …

Calculating the Costs of Clinical Trials | 12/1/2019

… the hidden costs of trial participation Of the three potential risks of participating in a clinical trial listed on the National Institutes of Health (NIH) website, two are related to the potential costs, hidden and … and established standards of care for a particular diagnosis.” 5 Aetna’s website stipulates that “all applicable plan limitations for coverage of out-of-network care will apply to routine care costs in clinical trials.” 6 …

Cigna

Calculating the Costs of Clinical Trials | 12/1/2019

… the hidden costs of trial participation Of the three potential risks of participating in a clinical trial listed on the National Institutes of Health (NIH) website, two are related to the potential costs, hidden and … will apply to routine care costs in clinical trials.” 6 Cigna’s clinical trial fact sheet notes that routine patient services, such as transplant-related services or select outpatient services, are managed the same way whether …

Calculating the Costs of Clinical Trials | 12/1/2019

… the hidden costs of trial participation Of the three potential risks of participating in a clinical trial listed on the National Institutes of Health (NIH) website, two are related to the potential costs, hidden and … will apply to routine care costs in clinical trials.” 6 Cigna’s clinical trial fact sheet notes that routine patient services, such as transplant-related services or select outpatient services, are managed the same way whether …

Harvard Pilgrim Health Care

Harvard Wyss Institute researchers demonstrate machine-guided engineering of AAV capsids | 11/30/2019

… of Engineering and Applied Sciences (SEAS). The study was funded by Harvard’s Wyss Institute for Biologically Inspired Engineering and the National Institutes of Health. PRESS CONTACT Wyss Institute for Biologically Inspired Engineering at Harvard University … and Women’s Hospital, Cambridge Health Alliance, Dana-Farber Cancer Institute, Harvard Pilgrim Health Care Institute, Hebrew SeniorLife, Joslin Diabetes Center, Judge Baker Children’s Center, Massachusetts Eye and Ear/Schepens Eye Research Institute, Massachusetts General Hospital …

Witnessing The Vaccine Injury Epidemic: We will NOT be Silent! We will NOT Give Up! | 11/29/2019

… Aug. 5, 2019. 69 MedAlerts. Vaccine adverse event reports made to the Vaccine Adverse Event Reporting System (VAERS) 2015-2019 . 70 Harvard Pilgrim Health Care, Inc. Electronic System for Public Health Vaccine Adverse Event Reporting System … from 2001 to 2009 . JAMA 2014; 311(17): 1778-1786. 104 National Institutes of Health. Rates of diagnosed cases of type 1 and type 2 diabetes on the rise among children, teens . Apr. 13, 2017. 105 …

Health Net

Allegheny Health Network’s Dr. Susan Manzi receives prestigious award for outstanding contributions to the field of rheumatology | PRWeb | 11/20/2019

Allegheny Health Network’s Dr. Susan Manzi receives prestigious award for outstanding contributions to the field of rheumatology Share Article Internationally known for her research and patient care in lupus, Dr. Manzi is recipient of the … program has been generously supported by organizations such as the National Institutes of Health (NIH), Department of Defense, Lupus Foundation of America and the Arthritis Foundation. Dr. Manzi has served on advisory boards for the …

It is not enough that we require data to be shared; we have to make sharing easy, feasible and accessible too! | BMJ | 7/23/2019

… sharing process. In an effort to support and facilitate data sharing, the EDCTP is working in collaboration with The Global Health Network to assess whether a cross-cutting knowledge hub around data sharing would help … possible. 3 4 Major funders such as the European Commission, National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation and The European and Developing Countries Clinical Trials Partnership (EDCTP; www.edctp.org ) are imposing contractual obligations …

Humana

Global Genitourinary Partnering Deal Trends, Players and Financials Directory 2014-2019 | PR Newswire | 10/24/2019

… of Canada Hainan Sihuan Pharmaceutical Hancock Jaffe Laboratories Harvard Stem Cell Institute Healthy.io Helix BioPharma HemoCleanse Hitachi Medical Systems Europe Humana Hydra Biosciences HydroCision Icahn School of Medicine at Mount Sinai Idera Pharmaceuticals IDIBELL ImpediMed … Development National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health National Kidney Registry NCPC GeneTech NephCure Kidney International Nephrogenex Nephros Neptune Technologies & Bioressources Nestle Health Science NeuralStem New York University School …

Three former Surgeons General to tackle the future of aging and wellness at ICAA 2019 conference | PRWeb | 10/9/2019

… panelists in the General Session at the ICAA 2019 conference. Dr. William Shrank, Chief Medical and Corporate Affairs Officer for Humana, will moderate the session. There will also be a special welcome video message from … Aging, the National Institute on Aging (one of the US National Institutes of Health), the US Department of Health and Human Services, Canada’s Special Senate Committee on Aging, and the British Columbia (Canada) Ministries of …

Indian Health Service

Tuesday, October 8, 2019 | Kaiser Health News | 10/8/2019

… shared during a congressional field hearing in Albuquerque. Dr. Loretta Christensen — the chief medical officer on the Navajo Nation for Indian Health Service, a partner in the research — said 781 women were screened during an … to definitively link vaping nicotine to cancer. Funded by the National Institutes of Health, the study was published Monday in the Proceedings of the National Academy of Sciences. (Bursztynsky, 10/7) Meanwhile, in the states — The …

For the Uniformed Public Health Service, Existential Questions Abound - Medscape | 9/18/2019

… even veterinarians are among its ranks. They are scattered across 22 federal government agencies, with the highest numbers in the Indian Health Service, the Food and Drug Administration, and the Centers for Disease Control and … including the Centers for Disease Control and Prevention and the National Institutes of Health. In the early 1940s, after a massive expansion in the budget of the PHS and the size of the Corps, Surgeon …

Anthony Fauci

Three decades before coronavirus, Anthony Fauci took heat from AIDS protesters | The Washington Post | 5/20/2020

Act Up, Fight Back, Fight AIDS!” The angry chanting grew louder as hundreds of protesters wove through the usually placid campus of the National Institutes of Health in Bethesda on May 21, 1990. With signs that read, “Red Tape Kills Us,” and “NIH — Negligence, Incompetence and Horror,” the AIDS activists marched toward a row of police officers in riot gear guarding Building One. Suddenly the pack parted and a small …

Francis Collins

US begins ‘warp speed’ push for coronavirus vaccine President Trump hopes will be ready by the end of the year - South Florida Sun Sentinel - South Florida Sun-Sentinel | 5/16/2020

National Institutes of Health is working in parallel to speed the science.At least four or five possible vaccines “look pretty promising” and one or two will be ready to begin large-scale testing by July with others to follow soon, NIH Director Francis Collins told The Associated Press."The big challenge now is to go big and everybody is about ready for that. And we want to be sure …

Donald Trump

US begins ‘warp speed’ push for coronavirus vaccine President Trump hopes will be ready by the end of the year - South Florida Sun Sentinel - South Florida Sun-Sentinel | 5/16/2020

President Donald Trump vowed to use “every plane, truck and soldier” to distribute COVID-19 vaccines he hopes will be ready by year’s end — even as the country’s top scientists gear up for a master … pan out. As the manufacturing side gets into place, the National Institutes of Health is working in parallel to speed the science.At least four or five possible vaccines “look pretty promising” and one or two …

George W. Bush

BARDA whistleblower Rick Bright speaks out on 60 Minutes | CBS News | 5/14/2020

… the director of BARDA from November 2016 until April 2020, when he was reassigned to a new position at the National Institutes of Health . In an 89-page whistleblower complaint, Bright claimed his reassignment was … law that passed both houses of Congress unanimously before President George W. Bush signed it into law. The government entity falls under the auspice of the Department of Health and Human Services (HHS) and is …

Susan Collins

Fauci warns quick reopening could spark another coronavirus outbreak | 5/12/2020

… the pandemic. Fauci is the head of the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health. With his long history of public health efforts , media savvy and … face masks appeared to be a largely partisan matter. Sen. Susan Collins of Maine appeared to be the only Republican to wear a face mask. More than 9 million Americans have been tested for the …

Alex Azar

Ousted vaccine director files whistleblower complaint alleging coronavirus warnings were ignored - CNNPolitics | 5/5/2020

… Biomedical Advanced Research and Development Authority since 2016 when he was reassigned last month to a narrower position at the National Institutes of Health. Read More An attorney for Bright told reporters on Tuesday he … the outbreak, alleging old disputes with HHS leadership – including Secretary Alex Azar and Robert Kadlec, the assistant secretary for preparedness and response – were exacerbated by clashes over the coronavirus and that he was eventually excluded …

Scott Gottlieb

ICYMI: Top takeaways from this week’s “Face the Nation” | 5/4/2020

… new hope for an eventual end to COVID-19 was ignited this week. A recently completed study led by the National Institutes of Health found that remdesivir shortened the recovery time for some coronavirus patients … claims of success, coronavirus showing persistent spread Former FDA commissioner Scott Gottlieb says the number of new cases and deaths related to coronavirus are rising in at least 20 states, showing the mitigation strategy is …

Mike Pence

Donald Trump turns the switch (opinion) - CNN | 5/3/2020

… takes of the week from CNN and other outlets. (CNN) Gone were the daily White House briefings with Vice President Mike Pence solemnly urging Americans to shelter at home to stop the spread of Covid … Wuhan and says it is investigating the matter. Meanwhile the National Institutes of Health abruptly terminated a research grant into the spread of coronaviruses from bats to people. The NIH confirmed the decision but wouldn’t …

Brad Pitt

Straight-talking Dr. Anthony Fauci is the voice Americans want to hear right now. So, who is he? | 5/3/2020

Brad Pitt . Fauci’s longtime official title is director of the National Institute of Allergy and Infectious Diseases , a part of the National Institutes of Health. But since becoming the face of this country’s COVID-19 pandemic, the career immunologist who has battled everything from AIDS to Ebola is increasingly referred to as America’s Doctor. And he’s in the headlines again this week, having been barred by the White House from …

Mitch McConnell

White House blocks Fauci testimony as Trump welcomes Senate return | US news | The Guardian | 5/2/2020

… leadership and no plan: is Trump about to fail the US on coronavirus testing? Read more Donald Trump , meanwhile, welcomed Mitch McConnell’s move to recall the Senate to Washington despite the congressional physician’s office reportedly … below … 100,000 lives lost.” Fauci, 79, has worked at the National Institutes of Health since 1968 . A source of measured, expert analysis on the Covid-19 outbreak in press briefings and interviews, his public profile …

Nancy Pelosi

White House blocks Fauci testimony as Trump welcomes Senate return | US news | The Guardian | 5/2/2020

Nancy Pelosi , “crazy” for not recalling the House and moved to remove a health department watchdog who wrote a critical report on the government’s pandemic response. According to researchers at Johns Hopkins university , the US has recorded more than 1.1m coronavirus cases and more than 65,000 deaths. On Friday, Trump told reporters : “Hopefully, we’re going to come in below … 100,000 lives lost.” Fauci, 79, has worked at the National Institutes …

Evan Vucci

The Health 202: Trump made the wrong bet on a coronavirus drug - The Washington Post | 4/30/2020

… National Institutes of Health. President Donald Trump speaks during a meeting about the coronavirus with Louisiana Gov. John Bel Edwards, not pictured, in the Oval Office of the White House, Wednesday, April 29, 2020, in Washington. (AP Photo/Evan Vucci) As U.S. deaths from novel coronavirus passed 60,000 yesterday, the trial found that remdesivir accelerated the recovery time of infected patients by 31 percent. The median recovery time for covid …

John Bel Edwards

More than half of US states will have begun reopening by the end of the week - CNN | 4/30/2020

… stay-at-home orders in an abundance of caution. “We need to use time to remain vigilant,” said Louisiana Gov. John Bel Edwards on Thursday after extending the state’s order through May 15. Over the … investigator for the clinical trial, which was sponsored by the National Institutes of Health. “In medicine, it’s never ending. We can always do better. And we want to do better.” A man is asked to …

Melinda Gates

DiscoveryBioMed and Monell Chemical Senses Center Awarded $1.68 Million Small Business Grant to Profile Bitter Taste Blockers | Business Wire | 4/29/2020

… WIRE)–Apr 29, 2020– DiscoveryBioMed, Inc. (DBM) has been awarded nearly $1.7 million over the next two years by the National Institutes of Health’s Small Business Technology Transfer Research (STTR) program to find bitter taste … 1 funding, and additional, separate support from the Bill and Melinda Gates Foundation to Monell and DBM, we showed that human taste bud cells in culture are a robust platform to study bitter taste and …

Adam Feuerstein

Gilead: Critical study of Covid-19 drug shows patients respond to treatment | 4/29/2020

… Critical study of Gilead’s Covid-19 drug shows patients are responding to treatment, NIH says By Matthew Herper @matthewherper and Adam Feuerstein @adamfeuerstein April 29, 2020 A vial of remdesivir ULRICH PERREY/POOL/AFP via … Office, Anthony Fauci, the director of NIAID, part of the National Institutes of Health, said the data are a “very important proof of concept” and that there was reason for optimism. He cautioned the data …

Eric Hargan

White House weighing plan to replace Azar | Yahoo News | 4/26/2020

… Eric Hargan, said the four people familiar with the talks. Senior officials’ long-standing frustrations with the health chief have mounted during the pressure-packed response to the Covid-19 outbreak, with White House aides angry this week about Azar’s handling of the ouster of vaccine expert Rick Bright . At a recent task force meeting, Azar assured Vice President Mike Pence that Bright’s move to the National Institutes of Health

Seema Verma

White House weighing plan to replace Azar | Yahoo News | 4/26/2020

… discussions. Among the names on the short list to replace Azar are White House coronavirus coordinator Deborah Birx, Medicare chief Seema Verma and deputy HHS Secretary Eric Hargan, said the four people familiar with the … assured Vice President Mike Pence that Bright’s move to the National Institutes of Health was a promotion — only for Bright and his lawyers to release a statement that he would soon file a whistleblower complaint …

Donald J. Trump

Coronavirus US live: Trump team mulls briefing changes in wake of disinfectant row | US news | The Guardian | 4/25/2020

… Facebook Twitter 10.46pm BST 22:46 Dr Anthony Fauci, White House coronavirus task force member and infectious diseases chief at the National Institutes of Health, said on Saturday that a randomized controlled trial is the only … Italy and Germany alone have issued more than 5.5m tests . Donald J. Trump (@realDonaldTrump) We have now Tested more than 5 Million People. That is more than any other country in the World, and even …

Chris Petersen

Scientist.com Launches COVID-19 Collaboration Center to Help Researchers in Fight Against Pandemic | 4/23/2020

… there is an urgent need for scientists and nonscientists to share ideas and pull together to find a cure,” stated Chris Petersen, Scientist.com’s CTO and Founder. “COVID-19 represents a historic challenge, but through expertise … pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $39 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network …

Alex Wong

HHS ousts vaccine expert as Covid-19 threat grows | Politico | 4/22/2020

… Alex Wong/Getty Images WhatsApp The abrupt ouster of a top vaccine expert at HHS has split officials who see it as either a boon for the nation’s Covid-19 response or the latest indication of a dysfunctional health department. Rick Bright, the director of the Biomedical Advanced Research and Development Authority, was transferred to a new, more narrow role at the National Institutes of Health this week, an HHS …

Rupert Vessey

NY pharma titans join federal agencies to speed treatment, vaccine work | 4/20/2020

… the public-private partnership, called ACTIV, to prioritize vaccine and drug candidates, streamline clinical trials and coordinate regulatory processes, the National Institutes of Health said Friday. The goal is to more rapidly and collectively respond … deliver innovative medicines that help patients prevail over serious diseases,” Rupert Vessey, executive vice president of research and early development at Bristol Myers Squibb, said. Other industry partners include New Brunswick, N.J.-based Johnson & Johnson …

Laura Wood

Genomics Industry Review 2015-2019 and Opportunity Outlook 2020-2030 | PR Newswire | 4/17/2020

… and private institutions. For instance, in 2018, in the U.S, The All of Us Research Program, a part of the National Institutes of Health, gave funds of $28.6 million for establishing three genome centers in … focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 …

Joe Biden

Doctors, nurses and scientists – not politicians – should lead coronavirus briefings (opinion) - CNN | 4/16/2020

… She’s the host of the podcast “Epidemic” with former US Ebola czar Ronald Klain, an adviser to Democratic presidential candidate Joe Biden. The opinions expressed in this commentary are her own. View more opinion at … servants at the Centers for Disease Control and Prevention, the National Institutes of Health, and the Food and Drug Administration, who have a lifetime of wisdom and expertise. We need to hear from officials in …

J. Joseph Kim

IVI, INOVIO, and KNIH to Partner with CEPI in Phase 1/2 Clinical Trial of INOVIO’s COVID-19 DNA Vaccine in South Korea | PR Newswire | 4/16/2020

… and we’re pleased to partner again to test the safety and immunogenicity of an urgently needed COVID-19 vaccine.” Dr. J. Joseph Kim , INOVIO’s President and CEO, said, “Developing a safe and effective COVID-19 … Trial Network, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, Plumbline Life Sciences, Regeneron, Roche/Genentech, University of Pennsylvania , Walter Reed Army …

Jim Cramer

Coronavirus live updates: Abbott Labs developing mass screening test | CNBC | 4/16/2020

… plainly unconstitutional’ VIDEO 1:53 01:53 Chubb CEO: Forcing insurers to pay pandemic loss claims is ‘plainly unconstitutional’ Mad Money with Jim Cramer State lawmakers have made efforts to extend business interruption coverage to coronavirus-related … the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, speaks about the coronavirus in the James Brady Press Briefing Room of the White House, Thursday, April 16, 2020, in Washington …